Scott L. Hansen, M.D., FACS is plastic and reconstructive surgeon with a primary appointment in the UCSF Department of Surgery, Division of Plastic and Reconstructive Surgery, and a secondary appointment in the Department of Orthopedic Surgery.
Dr. Hansen is a graduate of Eastern Virginia Medical School (EVMS). He participated in basic Science research throughout his 4 years at EVMS studying wound healing and peripheral nerve regeneration. He completed a combined General Surgery/Plastic Surgery residency at UCSF in 2005. Thereafter, he completed a 3-year post-doctoral research fellowship at UCSF. During this time, he was awarded a prestigious NIH-NRSA Grant that supported his work on heat shock proteins and cutaneous wound healing. He also completed a Hand and Microvascular Surgery Fellowship at UCLA.
Dr. Hansen was appointed Chief of the Division of Plastic Surgery at SFGH in 2007. He also serves as Chief of Hand and Microvascular Surgery at UCSF, co-director of the Hand and Upper Extremity Service at SFGH and, in 2014, Program Director of the UCSF Plastic Surgery Residency Program.
Dr. Hansen's clinical interests include reconstructive microsurgery (head and neck, breast, upper extremity, and lower extremity), general reconstructive plastic surgery and hand and upper extremity surgery--both congenital and traumatic. He is also the Hand and Microsurgery editor for both the Annals of Plastic Surgery and ePlasty (on-line Plastic Surgery Journal).
Dr. Hansen a principal investigator in the Surgical Research Lab at San Francisco General Hospital. (SFGH), maintaining a basic science lab. His interests include diabetic wound healing, fracture healing, limb development and hemangiomas. He has collaborations with basic scientists in the areas of development, angiogenesis and the extracellular matrix. In conjunction with David Young's Lab and under the leadership of Nancy Boudreau, Dr. Hansen's lab has numerous primary and collaborative research projects:
- Diabetic wound healing. Evaluation of the effects of homeobox genes on normal and deficient (diabetic) wound healing; specifically, the group 3 homeobox genes which accelerate diabetic wound healing through a variety of mechanisms.
- Hemangioma and Homeobox gene expression. Evaluation of the expression of homeobox genes in hemangiomas. Development of both an in vitro and in vivo model to evaluate the development and regression of these vascular tumors.
- Fracture healing. In collaboration with the Orthopedic Surgery Laboratory, Dr. Hansen's research group is evaluating the expression of homeobox genes in stable vs. unstable bone fractures. Investigation of diabetic bone healing as compared to normal bone healing.
Nerve repair. Development of a nerve gap model to evaluate the effect of Hox genes on nerve growth and repair.
- Stem cell biology. Evaluation of the contribution that stem cells have on adult wound healing. This will be compared to diabetic wound healing.